Adaptimmune Announces Board Changes
Oct 27, 2016 20:01 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Oct. 27, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) (“Adaptimmune” or the “Company”), a leader in T-cell therapy to treat cancer, today announced changes to its Board of...
Cytokinetics, Inc. Reports Third Quarter 2016 Financial Results
Oct 27, 2016 20:01 pm UTC| Business
Omecamtiv Mecarbil Advancing to Phase 3 With Agreement from FDAon Key Elements of Special Protocol Assessment VIGOR-ALS Enrolling Patients with ALS Who Have Completed VITALITY-ALS $65 Million Recently Received From...
Lombard Medical Reports 2016 Third Quarter, Nine-Month Financial Results
Oct 27, 2016 20:01 pm UTC| Business
IRVINE, Calif., Oct. 27, 2016 -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported financial results for...
I.D. Systems Sets Third Quarter 2016 Conference Call for November 9, 2016 at 4:45 p.m. ET
Oct 27, 2016 20:00 pm UTC| Business
WOODCLIFF LAKE, N.J., Oct. 27, 2016 -- I.D. Systems, Inc. (Nasdaq:IDSY), a leading provider of enterprise asset management technology and solutions for the Industrial Internet of Things, will hold a conference call on...
STRATTEC SECURITY CORPORATION Reports Fiscal 2017 First Quarter Operating Results
Oct 27, 2016 20:00 pm UTC| Business
MILWAUKEE, Oct. 27, 2016 -- STRATTEC SECURITY CORPORATION (NASDAQ:STRT) today reported operating results for the fiscal first quarter ended October 2, 2016. Net sales for the Company’s fiscal 2017 first quarter...
MGP Issues Further Updates Regarding Chemical Incident
Oct 27, 2016 19:52 pm UTC| Business
ATCHISON, Kan., Oct. 27, 2016 -- As previously reported, a chemical release occurred at MGP Ingredients' (Nasdaq:MGPI) plant in Atchison, Kan., at approximately 8 a.m. CT last Friday, Oct. 21. The reaction resulted in...
Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016
Oct 27, 2016 19:49 pm UTC| Business
OVERLAND PARK, Kan., Oct. 27, 2016 -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health...